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Secretory Microneme Proteins Induce T-Cell Recall Responses
in Mice Chronically Infected with Toxoplasma gondii
Iti Saraav,a Qiuling Wang,a Kevin M. Brown,a L. David Sibleya
aDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA
ABSTRACT Microneme (MIC) proteins play important roles in the recognition, adhe-
sion, and invasion of host cells by Toxoplasma gondii. Previous studies have shown
that MIC proteins are highly immunogenic in the mouse and recognized by human
serum antibodies. Here we report that T. gondii antigens MIC1, MIC3, MIC4, and
MIC6 were capable of inducing memory responses leading to production of gamma
interferon (IFN-) by T cells from T. gondii-infected mice. Production of IFN- was
demonstrated using enzyme-linked immunosorbent spot (ELISPOT) assay and also
intracellular cytokine staining. All four MIC antigens displayed very high sensitivity
(100%) and speciﬁcity (86 to 100%) for detecting chronic infection. Interestingly,
IFN- was produced by both CD4 and CD8 T cells in BALB/c mice but primarily
by CD4 T cells in C57BL/6 mice. Phenotypic characterization of IFN--producing
CD4 and CD8 T cells in BALB/c mice and CD4 T cells in C57BL/6 mice revealed
effector memory T cells (CD44hi CD62Llo) as the predominant cells that contributed
to IFN- production in response to MIC antigens. Effector memory responses were
seen in mice of different major histocompatibility complex class II (MHC-II) haplo-
types, suggesting that MIC antigens contain epitopes that are broadly recognized.
IMPORTANCE Current diagnosis of toxoplasmosis relies almost exclusively on anti-
body detection, and while detection of IgG provides a useful estimate of prior infec-
tion, it does not alone indicate immune status. In contrast, detection of IFN- re-
sponses to T. gondii antigens has been used to monitor immune responsiveness in
HIV-infected patients, thus providing valuable predictions about the potential for
disease reactivation. However, speciﬁc T. gondii antigens that can be used in assays
to detect cellular immunity remain largely undeﬁned. In this study, we examined the
diagnostic potential of microneme antigens of T. gondii using IFN- detection assays.
Our ﬁndings demonstrate that MIC antigens (MIC1, MIC3, MIC4, and MIC6) elicit
IFN- responses from memory T cells in chronically infected mice. Monitoring IFN-
production by T cells stimulated with MIC antigens provided high sensitivity and
speciﬁcity for detection of T. gondii infection in mice. Taken together, these studies
suggest that microneme antigens might be useful as an adjunct to serological test-
ing to monitor immune status during infection.
KEYWORDS antigen-speciﬁc T cells, gamma interferon detection assays, memory T
cells, microneme antigens, recall response, toxoplasmosis
Toxoplasma gondii is an obligate intracellular protozoan parasite that infects a widerange of warm-blooded hosts and causes toxoplasmosis. The infection is typically
acquired through exposure to soil, food, or water that is contaminated with oocysts
(containing sporozoites) or ingestion of undercooked meat containing viable tissue
cysts (containing bradyzoites) (1, 2). Infection is characterized by an acute phase, in
which parasites (i.e., sporozoites or bradyzoites) cross the intestinal epithelium, differ-
entiate to tachyzoites that migrate to draining lymph nodes, and widely disseminate
throughout the body. The acute infection is resolved by the development of protective
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immune responses. The acute phase is followed by chronic infection, characterized by
cysts containing bradyzoites in the skeletal muscle and central nervous system of the
infected host (3). Usually, T. gondii infection in healthy individuals is clinically asymp-
tomatic. However, the infection can be serious in several circumstances, including for
immunocompromised patients, who risk reactivation of chronic infection, and for naive
women during pregnancy, in whom infection can lead to congenital infection (4, 5).
Cell-mediated immunity plays a crucial role in host resistance to T. gondii infection
(6). In response to T. gondii infection, interleukin 12 (IL-12) signaling by macrophages
and dendritic cells stimulates T cells and natural killer (NK) cells to produce gamma
interferon (IFN-) (7, 8). IFN- is a major regulator of cell-mediated immunity which
activates hematopoietic and nonhematopoietic effector cells to control parasite repli-
cation (9–12). During Toxoplasma infection in the mouse, CD8 T cells are thought to
be the major effector cells, while CD4 T cells play a supportive role (13, 14). CD8 T
cells can both produce IFN- and kill infected cells, while CD4 T cells contribute to
control by IFN- secretion (15). It is primarily the production of IFN- and not perforin-
mediated cytolytic activity by CD8 T cells that is required for protection against T.
gondii infection (16). Memory T cells are critical for long-term protection against T.
gondii. CD4 and CD8 memory T cells are essential for the control of T. gondii
proliferation and prevent reactivation of disease (17–20). There are two primary subsets
of these long-lived T cells, known as central memory (Tcm) and effector memory (Tem)
T cells. Tcm cells mainly reside in secondary lymphoid organs, express high levels of
lymphoid homing molecules such as CCR7 and CD62L, and readily differentiate into
effector cells in response to antigen. Tem cells are primarily present in nonlymphoid
organs, do not express CCR7 and CD62L, and display immediate effector function (21,
22). One of the hallmarks of memory T cells is the capacity to mount an enhanced and
potent recall response through T-cell receptor recognition of cognate antigen loaded
on major histocompatibility complex (MHC) molecules of antigen-presenting cells. This
response is critical for long-term immunity but can also be exploited for diagnostic
detection of pathogens using puriﬁed microbial antigens.
In T. gondii, there are three main secretory compartments, called dense granules
(GRA proteins), rhoptries (ROP), and micronemes (MIC proteins), which release proteins
during or after host cell invasion (23, 24). Microneme secretion occurs constitutively at
low levels but is upregulated in response to environmental factors such as contact with
host cells or elevated intracellular calcium (23, 25, 26). The host cell invasion process of
T. gondii is initiated by the interaction of the proteins released from micronemes with
host cell receptors, primarily based on binding to carbohydrates (23, 24). For example,
MIC1, MIC4, and MIC6 are known to form a complex that exerts an important role in
host cell invasion (27, 28). We have previously shown that bovine serum albumin (BSA)
combined with the phosphodiesterase inhibitor zaprinast induced microneme secre-
tion in a protein kinase G-dependent manner and that this pathway was further
augmented by elevation of intracellular Ca2 (29). Excretory secretory antigens (ESA) of
T. gondii are known for their high immunogenicity in different experimental models,
and these antigens can induce protective immunity mediated by both antibody- and
cell-dependent mechanisms (30–32). Several microneme proteins, such as MIC1, MIC3,
MIC4, and MIC6, have been shown to be potential vaccine candidates based on studies
in the murine model of toxoplasmosis (33–35). Although it has been shown that
immunization with MIC1 and MIC4 confers protection against oral infection with ME49
in mice (33, 35), the mechanism of this protective effect is not known.
In this study, we examined memory T-cell responses to MIC antigens (MIC1, M2AP,
MIC3, MIC4, MIC6, and MIC10) and examined the phenotypes of these cells during
chronic infection. We report that MIC antigens (MIC1, MIC3, MIC4, and MIC6) induce
memory T-cell recall responses leading to production of IFN- during chronic infection
with T. gondii. Phenotypic analysis revealed that primarily CD4 but also CD8 effector
memory T cells that recognized MIC antigens were maintained in mice chronically
infected with T. gondii. These ﬁndings suggest that MIC antigens (MIC1, MIC3, MIC4, and
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MIC6) have potential as diagnostic markers for cell-mediated responses that could be
used to augment existing serological approaches.
RESULTS
Expression and puriﬁcation of endotoxin-free recombinant microneme pro-
teins. To study immunological responses to Toxoplasma, we cloned and puriﬁed
several of the major protein components present in ESA. MIC proteins were expressed
in Escherichia coli as soluble His-tagged proteins fused to Sumo, a bacterial ubiquitin-
like modifying protein that often confers solubility on partner proteins. MIC6, M2AP,
and MIC10 were expressed as full-length proteins, while MIC3, MIC4, and MIC1 were
expressed as truncated proteins to enhance their expression and solubility (Table 1).
The soluble recombinant proteins were puriﬁed by Ni afﬁnity chromatography. SDS-
PAGE analysis of the puriﬁed recombinant proteins showed that they migrated with the
predicted molecular mass of each protein construct together with the Sumo tag
(Table 1). The lower band of 12.5 kDa (migrates to 23 kDa) observed in some of these
protein preparations likely represents a breakdown product of Sumo (Table 1).
Endotoxin-contaminated proteins used in immunological assays can initiate strong
responses due to engagement of Toll-like receptor 4 (TLR4) (36, 37). Therefore, the
proteins were treated with endotoxin removal resin containing modiﬁed polylysine
afﬁnity ligand. After treatment, endotoxin levels of puriﬁed MIC proteins were 0.1
endotoxin unit (EU)/mg, as determined by a Limulus assay (Table 1). An endotoxin level
below 1 EU/mg (0.1 ng/mg) is considered a safe limit, as it typically does not interfere
with assays (38, 39).
Detection of MIC antigens using IFN- ELISPOT assay. To identify whether T cells
from T. gondii-infected mice can respond to MIC antigens ex vivo, splenocytes obtained
from naive mice and mice chronically infected with T. gondi were stimulated with
puriﬁed MIC antigens. Optimal concentrations of MIC protein (MIC1, MIC3, MIC4, and
MIC6) were determined using different doses to perform an IFN- enzyme-linked
immunosorbent spot (ELISPOT) assay (Fig. 1B). Concentrations of 1 g/ml for MIC1,
MIC4, and MIC6 and 0.5 g/ml for MIC3 were selected, as they resulted in positive
responses in infected mice and lower responses in naive mice (Fig. 1B). To evaluate two
different MHC haplotypes, experiments were conducted with both BALB/c mice (H-2d
haplotype) and C57BL/6 mice (H-2b haplotype). We observed that both BALB/c and
C57BL/6 chronically infected mice produced statistically signiﬁcantly higher levels of
IFN- than naive mice when stimulated with MIC antigens (MIC1, MIC3, MIC4, and MIC6)
(Fig. 2). In contrast, no signiﬁcant response was seen in IFN- levels of BALB/c and
C57BL/6 chronically infected mice when stimulated with M2AP and MIC10 (Fig. 2). ESA
was used as a positive control, and stimulation resulted in signiﬁcantly higher produc-
tion of IFN- in CD4 T cells from T. gondii-infected mice than from naive mice (Fig. 2).
As expected, the mitogen concanavalin A (ConA) stimulated responses in both groups
of animals (Fig. 2). We did not observe any response to Sumo, conﬁrming that positive
response observed in the ELISPOT assay was speciﬁc to MIC antigens and not due to
underlying endotoxin contamination. Receiver operating characteristic (ROC) curve
analyses are typically used to determine whether an assay fulﬁlls the criterion for a




No. of amino acids
in construct
Mol wt (kDa) of: Endotoxin level (EU/ml)
Tested fragment
Tested fragment
with Sumo Before treatment After treatment
MIC1 48.6 20–340 35.2 58.2 2.878 0.051
M2AP 34.6 22–330 34.6 57.6 3.114 0.066
MIC3 40.5 134–383 27.4 50.2 3.209 0.048
MIC4 63 58–231 19.0 42 3.212 0.068
MIC6 36.7 23–349 36.7 59.7 3.003 0.053
MIC10 23.1 1–198 23.1 46.2 2.602 0.043
Sumo 12.5 1–100 12.5 3.124 0.071
Memory T-Cell Responses to MIC Antigens
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FIG 1 Separation of puriﬁed MIC fusion proteins by SDS-PAGE. (A) Coomassie blue-stained gel of recombinant proteins. Sumo was used as a control
for the fusion proteins. The smaller bands in the recombinant protein lanes likely represent Sumo (12.5 kDa) as a breakdown product. Values on the left
are molecular masses, in kilodaltons. (B) Dose-response curves to identify optimal concentration of MIC proteins for ELISPOT assay. Splenocytes from
C57BL/6 mice that were naive (n 3) or chronically infected with T. gondii (n 3) were stimulated with different concentrations of MIC proteins for 24
h. For each protein, concentrations that resulted in the maximum positive response in infected mice with minimal responses in naive mice were selected.
Data are presented as mean of IFN- spots/2.5 106 cells  SD from three mice in one experiment.
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reliable diagnostic test based on relative sensitivity and speciﬁcity (40, 41). We per-
formed ROC analyses to evaluate the speciﬁcity and sensitivity of MIC antigens in the
ELISPOT assay. MIC antigens that gave positive responses in the ELISPOT assay were
used for ROC analyses. In the IFN- ELISPOT assay, MIC1, MIC3, MIC4, and MIC6 had a
speciﬁcity of 100%, and sensitivity ranged from 86 to 100% in both strains of mice
(Table 2). These ﬁndings indicate that MIC antigens (MIC1, MIC3, MIC4, and MIC6) may
provide a useful diagnostic tool for detection of IFN- secretion during chronic infec-
tion.
Detection of IFN- production by intracellular cytokine staining. To characterize
T. gondii-speciﬁc CD4 and CD8 T-cell responses, splenocytes from naive and chron-
ically infected mice were examined by intracellular staining for IFN-. Figure S1A in the
supplemental material shows the gating strategy used for the intracellular staining for
IFN-. In splenocytes from infected mice BALB/c mice stimulated with ESA, 14% of
CD3 IFN- cells were CD4 T cells, while 4% were CD8 T cells (Fig. S1B).
Stimulation of splenocytes with MIC antigens resulted in signiﬁcant increases in IFN-
production by both CD4 and CD8 T cells from infected mice in comparison to that
in naive mice, but CD4 T cells produced greater amounts of IFN- than CD8 T cells
FIG 2 ELISPOT assay of IFN- production by splenocytes from mice that were naive or chronically infected with
T. gondii. Mouse splenocytes were collected 30 days after T. gondii infection and stimulated with ESA as an
antigen-speciﬁc positive control (1 g/ml), ConA as a nonspeciﬁc positive control (1 g/ml), Sumo as a negative
control (1 g/ml), or MIC1, M2AP, MIC4, MIC6, or MIC10 (1 g/ml), or MIC3 (0.5 g/ml). Cells were stimulated for
24 h from either BALB/c (A) or C57BL/6 (B) mice. ELISPOT analysis was performed on 6 naive and 12 chronically
infected BALB/c mice and 7 naive and 11 chronically infected C57BL/6 mice. Ordinary one-way ANOVA with Sidak’s
multiple-comparison test was used to compare ELISPOT results. *, P 0.05; ***, P 0.001; ****, P 0.0001. ns,
nonsigniﬁcant.




Cutoff Speciﬁcity (%) Sensitivity (%) Cutoff Speciﬁcity (%) Sensitivity (%)
MIC1 359 100 100  408 100 100
MIC3 416 100 100 398 100 93
MIC4 398 100 88 234 100 93
MIC6 402 100 88 312 100 86
aC57BL/6 mice included 7 naive and 11 infected mice.
bBALB/c mice included 6 naive and 12 infected mice.
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(Fig. 3). As expected, stimulation with ConA triggered IFN- production in both naive
and infected mice (Fig. 3).
For C57BL/6 mice also, ESA-stimulated splenocytes from infected mice showed
higher numbers of CD4 T cells than CD8 T cells among CD3 IFN- cells (Fig. S1B).
Stimulation of splenocytes with MIC antigens resulted in signiﬁcant increases in IFN-
production by CD4 T cells from infected mice in comparison to those from naive mice
(Fig. 4A). In contrast, most MIC antigens, with the exception of MIC1, did not show a
signiﬁcant difference in IFN--producing CD8 T cells (Fig. 4B).
Analysis of IFN- production by memory T cells.Memory T cells play a critical role
in providing long-term immunity. During secondary challenge, populations of antigen-
speciﬁc memory T cells have the capacity to mediate vigorous and accelerated re-
sponses. However, the relative contributions of different memory subsets (either CD4
or CD8 T cells) to recall responses to T. gondii antigens is unknown. To identify the
frequencies of memory T-cell subsets producing IFN- in response to MIC antigens, we
characterized memory T-cell subsets within CD4 and CD8 T cells. Figure 5A shows
the gating strategy used for analyzing the four different T-cell populations, based on
expression of cell surface markers CD44 and CD62L. We classiﬁed cells based on the
expectations that central memory T cells are CD44hi CD62Lhi, effector memory cells are
CD44hi CD62Llo, effector T cells are CD44	 CD62Llo, and naive cells are CD44	 CD62Lhi.
For BALB/c mice, memory T-cell subset analysis was done both on CD4 IFN- and
CD8 IFN- cells. Since in C57BL/6 mice IFN- was predominantly made by CD4 T
cells, memory T-cell subset analysis was done only on CD4 IFN- T cells. We found
that both in IFN--producing CD4 and CD8 T cells in BALB/c mice and in IFN--
producing CD4 T cells in C57BL/6 mice, Tem cells (CD44hi CD62Llo) were the predom-
inant cells that contributed to IFN- production in response to MIC1 antigen (Fig. 5B).
Similar results were obtained with MIC3, MIC4, and MIC6 (data not shown). Although
the total number of memory cells was low, approximately 70 to 85% of CD4 IFN-
T cells and 58 to 70% of CD8 IFN- T cells were CD62Llo (Fig. 5B). These ﬁndings
FIG 3 Intracellular cytokine staining of IFN- production by CD4 and CD8 T cells from BALB/c mice. Splenocytes
were obtained from mice that were naive or chronically infected with T. gondii and stimulated with ESA (1 g/ml),
ConA (1 g/ml), SUMO (1 g/ml), MIC1, MIC4, or MIC6 (1 g/ml), or MIC3 (0.5 g/ml) for 24 h. The experiment was
performed on 5 naive and 10 chronically infected mice. Ordinary one-way ANOVA with Sidak’s multiple-comparison
test was used to compare results between naive and infected cells.
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indicate that MIC antigen-experienced CD4 and CD8 T cells were maintained as
effector memory cells in mice chronically infected with T. gondii.
DISCUSSION
Excretory secretory antigens (ESA) of T. gondii play a key role in stimulation of
antibody responses the host immune system during T. gondii infection (42). ESA also
elicit strong delayed-type hypersensitivity reactions in humans, as detected by skin test,
yet the antigens responsible for this response remain unknown (30, 43). Previous mass
spectrometry studies done in our lab revealed ESA to be highly enriched in microneme
proteins (29). Moreover, the secretory MIC1, MIC3, MIC4, and MIC6 proteins have been
shown to induce protective immunity against T. gondii in the murine model (33, 34). In
this study, we focused on the role of these secretory antigens in inducing immuno-
logical memory during chronic infection in the mouse. Our ﬁndings indicate that MIC
proteins (MIC1, MIC3, MIC4, and MIC6) elicit cellular immune responses characterized
by effector memory T cells that are activated to secrete IFN-. These ﬁndings suggest
that MIC antigens may be useful for developing diagnostic methods that detect
cell-mediated responses based on IFN- secretion.
Currently diagnosis of chronic toxoplasmosis is based almost entirely on antibody
responses where chronic infections are best established based on IgG, while early
infection is monitored by IgM (44–49). Although standard serological tests provide
excellent assessment of prior infection status, including discrimination between re-
cently acquired and long-term infections, they do not provide an assessment of
immunological responsiveness. As well, serological testing in newborns is complicated
by the potential for transfer of maternal IgG antibodies. Consequently, it has been
shown that testing of cell-mediated immunity in assays, such as detection of IFN-
release by peripheral blood leukocytes, can provide greater discrimination of infection
status in newborns (50, 51). These studies relied on whole parasite antigen, which
FIG 4 Intracellular cytokine staining of IFN- production by CD4 and CD8 T cells from C57BL/6 mice.
Splenocytes were obtained from mice that were naive or chronically infected with T. gondii and stimulated with
ESA as an antigen-speciﬁc positive control (1 g/ml), ConA as a nonspeciﬁc positive control (1 g/ml), Sumo as a
negative control (1 g/ml), MIC1, MIC4, or MIC6 (1 g/ml), or MIC3 (0.5 g/ml) for 24 h. The experiment included
5 naive and 10 chronically infected mice. Ordinary one-way ANOVA with Sidak’s multiple-comparison test was used
to compare results between naive and infected cells.
Memory T-Cell Responses to MIC Antigens
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performed well, but the authors commented that identiﬁcation of speciﬁc antigens may
improve test performance (50). In a very different patient population, IFN--speciﬁc
ELISPOT assays were used to estimate the risk of toxoplasmic encephalitis relapse in
patients infected with HIV-1 and on highly active antiretroviral therapy (HAART) (49).
Cell-mediated responses to T. gondii antigens in such patients may be a better predictor
of the potential for reactivation of central nervous system (CNS) disease versus total
CD4 levels that are normally monitored to assess immune status (49). This study was
also based on using whole T. gondii soluble antigens from tachyzoites to detect
immune status, and greater discrimination might be achieved using speciﬁc antigens.
Detection of IFN- secretion offers an independent means to assess prior infection,
a method that has gained popularity recently for other chronic infections, such as
tuberculosis (52–54). An IFN- release assay known as T-SPOT TB and based on an
ELISPOT test is one of the most sensitive methods used for detecting tuberculosis
infection. This method is based on the ability of specialized immune cells (dendritic
cells and macrophages) to present antigen on MHC class II receptors to memory T cells,
which, in turn, produce IFN-. Previous studies using IFN- release assays to monitor
IFN- secretion in T. gondii-infected mice indicate that responses to several GRA and
FIG 5 Relative contribution of memory T-cell subsets to production of IFN- in response to MIC antigens. (A) The
gating strategy for evaluation of CD4 and CD8 memory T-cell subsets producing IFN- using CD44 and CD62L
markers is shown on the left. The plot on the right present the numbers (shown within the boxes) of CD4 and
CD8 memory T-cell subsets producing IFN- in splenocytes obtained from BALB/c mice chronically infected with
T. gondii when stimulated with 1 g/ml of MIC1 for 24 h. (B) Frequencies of memory T-cell subsets producing IFN-
in CD4 and CD8 T cells in response to MIC1 in splenocytes obtained from BALB/c and C57BL/6 mice chronically
infected with T. gondii (n 10). Since in C57BL/6 mice IFN-  was predominantly made by CD4 T cells, memory
T-cell analysis was done on CD4 IFN-   T cells.
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ROP secretory antigens are detected very early after infection (55). Additionally, it has
been shown that the parasite proteins GRA1 and SAG1 elicit production of IFN- from
peripheral blood cells of chronically infected women (56). These ﬁndings suggest that
it may be possible to develop assays to monitor IFN- release in response to speciﬁc T.
gondii proteins as an alternative to serological assays for detecting both acute and
chronic infections.
In this study, we developed an IFN- release assay based on the ELISPOT assay to
quantify T-cell responses to recombinant MIC antigens found in ESA. Highly speciﬁc
responses were detected from T cells from infected BALB/c and C57BL/6 mice stimu-
lated with MIC1, MIC3, MIC4, and MIC6, suggesting that conserved MHC class II (MHC-II)
epitopes are contained in these antigens. Based on ROC curve analyses, all four MIC
antigens displayed very high sensitivity (100%) and speciﬁcity (86 to 100%). Of the MIC
antigens tested, MIC1 showed the best combination of sensitivity and speciﬁcity.
Hence, the IFN- ELISPOT assay using MIC1 or other antigens may be useful in
detecting toxoplasma infection in other animals as well.
Although we have not tested ROC using crude ESA, the use of recombinant antigens
offers several advantages. First, by using recombinant antigens, the production of
material can be easily scaled and quality controlled from batch to batch. Second, it is
evident from deconvolving the mixture of proteins found in ESA that not all antigens
are capable of eliciting IFN- secretion responses. Hence, using puriﬁed recombinant
antigens increases the speciﬁc activity of the assay. Finally, use of recombinant antigens
may also allow avoidance of cross-reactive antigens, which would confound sensitivity
and speciﬁcity performance.
Although our ﬁndings show promise for detecting infection in mice, there are
several additional challenges that will need to be met if these studies are to be
extended to other animals. First, it will be important to assess the degree to which MIC
antigens are recognized across a broader panel of MHC-II receptors from different
species. Second, the performance of the recombinant antigens described here may
differ in sensitivity and/or speciﬁcity in the case of other animals, including humans.
Finally, the performance of puriﬁed recombinant antigens as a means to detect
infection based on IFN- stimulation may differ in acute infection versus chronic and for
individuals of different immune statuses. Our studies stand as a benchmark for such
future studies aimed at extending the utility of these antigens for diagnosis in other
species, including humans.
During chronic T. gondii infection, long-term immunity is mainly mediated by T-cell
production of IFN- required for controlling parasite reactivation (8, 57). Consequently,
we also tested the ability of these four MIC antigens to induce IFN- production by
CD4 and CD8 T cells in T. gondii-infected mice. In BALB/c mice, IFN- was found to
be produced by both CD4 and CD8 T cells, although responses were higher in CD4
T cells. This observation is in line with another study, in which CD4 T cells were
reported to produce more IFN- than did CD8 T cells among splenocytes from
chronically infected BALB/c mice stimulated with tachyzoite lysate antigen (58). We
found that IFN- was primarily produced by CD4 T cells in C57BL/6 mice. These results
corroborate those of a previous study that reported CD4 T cells as the main IFN--
producing cells among splenocytes obtained ex vivo from C57BL/6 mice immunized
with T. gondii (59). The ability of MIC antigens to elicit IFN- secretion for both subtypes
is consistent with previous ﬁndings indicating that these antigens can drive protective
immune responses in the mouse (33–35).
To decipher the phenotypes of memory T-cell subsets involved in IFN- production
in response to MIC antigens, we characterized CD4 and CD8 T cells using phenotypic
markers. We chose a time point of 4 weeks postinfection in order to avoid T-cell
exhaustion, which has been described in other studies (60). Both CD4 and CD8 T
cells producing IFN- in response to MIC antigens were found to be almost exclusively
CD62Llo cells, suggesting the presence of an extended pool of effector memory cells
that produce IFN- in a recall response in T. gondii chronic infection. This result is
consistent with the effector function of Tem cells, which, although short-lived (61),
Memory T-Cell Responses to MIC Antigens
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contribute to IFN- production and protection against chronic intracellular parasitic
infections with Plasmodium chabaudi and Trypanosoma cruzi in the mouse (62–64).
Taken together, our data demonstrate that MIC antigens found in ESA induce T
memory recall responses that lead to IFN- secretion in animals chronically infected
with T. gondii. Monitoring such responses may provide an adjunct to existing serolog-
ical tests either to establish infection or to monitor immune responsiveness. Our
ﬁndings also suggest that MIC antigens induce IFN--producing CD4 and CD8
memory T cells that are maintained and activated against a secondary challenge; hence,
these antigens might be exploited for development of protective vaccines.
MATERIALS AND METHODS
Ethics. Animal studies were conducted according to the U.S. Public Health Service policy on human
care and use of laboratory animals. Animals were maintained in facilities approved by the Association for
Assessment and Accreditation of Laboratory Animal Care (66). Animal studies were approved by the
Institutional Animal Studies Committee at the School of Medicine, Washington University, St. Louis, MO.
Parasite culture and preparation of ESA. Toxoplasma strain RH tachyzoites were maintained in
human foreskin ﬁbroblasts as previously described (65). Excretory secretory antigens (ESA) were prepared
as described previously, with slight modiﬁcation (29). Parasites were harvested from fully egressed
cultures and resuspended in extracellular (EC) buffer (5 mM KCl, 142 mM NaCl, 1 mM MgCl2, 1.8 mM
CaCl2, 5.6 mM D-glucose, 25 mM HEPES [pH 7.4]). Tissue culture-grade 24-well plates were coated with 1%
bovine serum albumin (BSA) in EC buffer at 4°C overnight. The next day, the wells were washed with EC
buffer to remove BSA just prior to stimulating microneme secretion. For stimulation of ESA secretion, 500
l of freshly harvested parasites was added to BSA-coated wells and 500 l of 1 mM zaprinast
(Sigma-Aldrich) in EC buffer was added. Parasites were allowed to secrete for 20 min at 37°C. After
20 min, plates were chilled for 5 min, the liquid was collected and centrifuged at 2,700 rpm and 4°C for
5 min, and the supernatant was retained as the ESA fraction. The ESA fraction was buffer exchanged with
phosphate-buffered saline (PBS) using Amicon (Millipore Sigma) centrifugal ﬁlters (3-kDa cutoff), and the
retained fraction was stored at 	80°C. The protein concentration was estimated using a bicinchoninic
acid (BCA) protein assay kit (Thermo Fisher).
Cloning, expression, and puriﬁcation of MIC proteins. MIC1, MIC3, and MIC4 constructs and
M2AP, MIC6, and MIC10 full-length genes were ampliﬁed by PCR using T. gondii ME49 strain cDNA as the
template with speciﬁc forward and reverse primers (Table S1). After treatment with the BsaI and XbaI
restriction enzymes, PCR products were cloned into the pE-Sumo vector and transformed into competent
E. coli DH10B. Positive clones were identiﬁed using colony PCR screening and conﬁrmed by DNA
sequencing. For expression of the Sumo fusion proteins, pE-Sumo-fusion plasmids were isolated from the
DH510B cells and chemically transformed into E. coli BL21(DE3) Rosetta cells. A single pE-Sumo-positive
colony was inoculated into TB broth with 100 g/ml of ampicillin until the optical density reached
between 0.6 and 0.8, and the culture was induced with 0.5 mM isopropyl--D-thiogalactopyranoside
(IPTG) at 15°C overnight. Cells were harvested and the cell pellet was resuspended in lysis buffer
(Sigma-Aldrich) containing lysozyme and protease inhibitor cocktail. Recombinant MIC proteins were
puriﬁed using an HIS-Select nickel afﬁnity gel (Sigma-Aldrich) using different concentration of imidazole.
The purity of eluted proteins was analyzed by 12% SDS-PAGE electrophoresis and staining with Instant
Blue Coomassie stain (Expedeon). Recombinant proteins were dialyzed against PBS (pH 7.2) and treated
with Pierce high-capacity endotoxin removal resin (Thermo Fisher) for 8 to 12 h according to the
manufacturer’s instructions. The recombinant MIC proteins were quantiﬁed by separation on SDS-PAGE
gels, staining with Instant Blue Coomassie stain, and comparison with a standard curve of known
concentrations of BSA. Samples were then stored at 	80°C until use.
Experimental design for in vivo infections. Experiments were performed on 8-week-old speciﬁc-
pathogen-free (SPF)-grade female BALB/c and C57BL/6 mice purchased from Jackson Laboratory. Studies
were approved by Division of Comparative Medicine, Washington University. Animals were maintained
in an AAALAC-approved animal facility. For chronic infection, mice were infected by oral administration
of 5 to 10 cysts of T. gondii type II strain ME49. Enzyme-linked immunosorbent assay (ELISA) was
performed using serum to conﬁrm that the mice were infected. At 30 days postinfection, splenocytes
were collected and stimulated with antigens.
Preparation of mouse splenocytes. Spleens from naive and T. gondii-infected mice were harvested
and splenocytes were released by grinding the spleen through a 70-m-pore-size nylon cell strainer.
Splenocytes were centrifuged at 400 g for 10 min at 4°C, and red blood cells (RBCs) were removed
using RBC lysis buffer (Biolegend) for 2 min on ice. Splenocytes were then washed in sterile PBS and
Hanks’ balanced salt solution (HBSS; Corning). Cells were quantitated using a hemacytometer. For
ELISPOT assay, splenocytes were resuspended in CTL medium (Immunospot) supplemented with
100 U/ml of penicillin and 100 g/ml of streptomycin (M&C Gene Technology). For IFN- intracellular
(cytokine staining) and phenotypic characterization, splenocytes were resuspended in RPMI 1640 me-
dium (Gibco) and 10% heat-inactivated fetal bovine serum (HyClone).
IFN- ELISPOT assay. Brieﬂy, 2.5 105 splenocytes per well were stimulated in precoated wells of
polyvinylidene diﬂuoride (PVDF) strip plates (Immunospot) with medium alone, ESA (1 g/ml) for a
positive control, concanavalin (ConA; Sigma-Aldrich; 1 g/ml) for a nonspeciﬁc-T-cell positive control,
Sumo (1 g/ml) for a negative control, or different concentrations of MIC antigens (MIC1, 1 g/ml; M2AP,
1 g/ml; MIC3, 0.5 g/ml; MIC4, 1 g/ml; MIC6,1 g/ml; and MIC10, 1 g/ml) for 24 h at 37°C and 5% CO2.
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After the plate was washed and developed according to the manufacturer’s instructions, the antigen
recall response was determined by counting the number of spots (IFN--producing cells) per well per
treatment. The numbers of IFN--producing T cells following stimulation with T. gondii antigens were
detected and calculated using an ELISPOT reader (Immunospot S6 Core; CTL). Receiver operating
characteristic (ROC) curves were used to evaluate the accuracy of the ELISPOT assay. Speciﬁcity,
sensitivity, and cutoff values for MIC1, MIC3, MIC4, and MIC6 were determined for both BALB/c and
C57BL/6 mice using the ROC curves.
Intracellular cytokine staining and immunophenotypic characterization. Brieﬂy, 2 105 spleno-
cytes per well were stimulated with concentrations of MIC antigens similar to those used in the previous
experiment. After stimulation, cells were treated with GolgiStop protein transport inhibitor (1 l/ml; BD
Biosciences) for 6 h. Cells were washed and stained with 5 l of LIVE/DEAD Aqua (Invitrogen) and 50 l
of anti-mouse CD3-allophycocyanin (APC)-Cy7, CD4-peridinin chlorophyll protein (PerCP)-Cy5.5, CD8-
ﬂuorescein isothiocyanate (FITC), CD44-phycoerythrin (PE), and CD62L-APC antibodies (Biolegend, USA)
prepared in PBS plus 0.5% BSA for 30 min at 4°C in the dark. Cells were ﬁxed and permeabilized with
200 l of 1 BD Cytoﬁx/Cytoperm buffer for 20 min at 4°C and then washed with 200 l of 1 BD
Perm/Wash buffer. Next cells were incubated with 50 l of anti-mouse IFN-–PE–Cy7 intracellular
staining antibody (Biolegend) or anti-mouse PE-Cy7 IgG1,  isotype control (Biolegend), for 30 min at 4°C
in the dark. Cells were washed and ﬁnally resuspended in 1 BD Perm/Wash buffer. Data analysis was
carried out using FlowJo v10 software. Events were gated on singlets, live cells, and lymphocytes using
forward scatter and side scatter. Analysis was done using isotype-matched controls as a reference. To
identify the frequencies of memory T-cell subsets producing IFN- in response to MIC antigens in an ex
vivo assay, gated CD4 IFN- and CD8 IFN- T cells were evaluated using CD44 and CD62L markers.
Cells were acquired using a BD LSRII cytometer (BD Biosciences).
Statistical analyses. Data were analyzed in Prism using the D’Agostino and Pearson test to conﬁrm
that they were normally distributed. Ordinary one-way analysis of variance (ANOVA) was used to
compare ELISPOT results and IFN--positive staining between naive and infected cells. P values of
0.05,0.01,0.001, and0.0001 were considered statistically signiﬁcant. The analyses were done by
GraphPad Prism 7.0 software. ROC curves were used to evaluate the accuracy of the ELISPOT assay. The
cutoff value was determined from the ROC curve by choosing the value that gave the best sensitivity and
speciﬁcity.
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